Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Molecular Pharmaceutics
|
August 26, 2014
Self-immolative polycations as gene delivery vectors and prodrugs targeting polyamine metabolism in cancer
Yu Zhu, Jing Li, Shrey Kanvinde, et al.
Journal of Medicinal Chemistry
|
July 11, 2006
Further structural exploration of trisubstituted asymmetric pyran derivatives (2S,4R,5R)-2-benzhydryl-5-benzylamino-tetrahydropyran-4-ol and their corresponding disubstituted (3S,6S) pyran derivatives: a proposed pharmacophore model for high-affinity interaction with the dopamine, serotonin, and norepinephrine transporters
Shijun Zhang, Fernando Fernandez, Stuart Hazeldine, et al.
Journal of Medicinal Chemistry
|
April 16, 2008
Bioisosteric heterocyclic versions of 7-{[2-(4-phenyl-piperazin-1-yl)ethyl]propylamino}-5,6,7,8-tetrahydronaphthalen-2-ol: identification of highly potent and selective agonists for dopamine D3 receptor with potent in vivo activity
Swati Biswas, Stuart Hazeldine, Balaram Ghosh, et al.
Journal of Medicinal Chemistry
|
August 11, 2012
Low molecular weight amidoximes that act as potent inhibitors of lysine-specific demethylase 1
Stuart Hazeldine, Boobalan Pachaiyappan, Nora Steinbergs, et al.
Journal of Medicinal Chemistry
|
March 31, 2011
Further structure-activity relationship studies on 4-((((3S,6S)-6-benzhydryltetrahydro-2H-pyran-3-yl)amino)methyl)phenol: identification of compounds with triple uptake inhibitory activity as potential antidepressant agents
Bhaskar Gopishetty, Stuart Hazeldine, Soumava Santra, et al.
The Journal of Biological Chemistry
|
October 26, 2011
Alternative spermidine biosynthetic route is critical for growth of Campylobacter jejuni and is the dominant polyamine pathway in human gut microbiota
Colin C Hanfrey, Bruce M Pearson, Stuart Hazeldine, et al.
Investigational New Drugs
|
May 11, 2002
Preclinical efficacy evaluations of XK-469: dose schedule, route and cross-resistance behavior in tumor bearing mice
Lisa Polin, Kathryn White, Juiwanna Kushner, et al.
Medchemcomm
|
January 8, 2013
Polyamine-based small molecule epigenetic modulators
Shiv K Sharma, Stuart Hazeldine, Michael L Crowley, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Molecular Pharmaceutics
|
August 26, 2014
Self-immolative polycations as gene delivery vectors and prodrugs targeting polyamine metabolism in cancer
Yu Zhu, Jing Li, Shrey Kanvinde, et al.
Journal of Medicinal Chemistry
|
July 11, 2006
Further structural exploration of trisubstituted asymmetric pyran derivatives (2S,4R,5R)-2-benzhydryl-5-benzylamino-tetrahydropyran-4-ol and their corresponding disubstituted (3S,6S) pyran derivatives: a proposed pharmacophore model for high-affinity interaction with the dopamine, serotonin, and norepinephrine transporters
Shijun Zhang, Fernando Fernandez, Stuart Hazeldine, et al.
Journal of Medicinal Chemistry
|
April 16, 2008
Bioisosteric heterocyclic versions of 7-{[2-(4-phenyl-piperazin-1-yl)ethyl]propylamino}-5,6,7,8-tetrahydronaphthalen-2-ol: identification of highly potent and selective agonists for dopamine D3 receptor with potent in vivo activity
Swati Biswas, Stuart Hazeldine, Balaram Ghosh, et al.
Journal of Medicinal Chemistry
|
August 11, 2012
Low molecular weight amidoximes that act as potent inhibitors of lysine-specific demethylase 1
Stuart Hazeldine, Boobalan Pachaiyappan, Nora Steinbergs, et al.
Journal of Medicinal Chemistry
|
March 31, 2011
Further structure-activity relationship studies on 4-((((3S,6S)-6-benzhydryltetrahydro-2H-pyran-3-yl)amino)methyl)phenol: identification of compounds with triple uptake inhibitory activity as potential antidepressant agents
Bhaskar Gopishetty, Stuart Hazeldine, Soumava Santra, et al.
The Journal of Biological Chemistry
|
October 26, 2011
Alternative spermidine biosynthetic route is critical for growth of Campylobacter jejuni and is the dominant polyamine pathway in human gut microbiota
Colin C Hanfrey, Bruce M Pearson, Stuart Hazeldine, et al.
Investigational New Drugs
|
May 11, 2002
Preclinical efficacy evaluations of XK-469: dose schedule, route and cross-resistance behavior in tumor bearing mice
Lisa Polin, Kathryn White, Juiwanna Kushner, et al.
Medchemcomm
|
January 8, 2013
Polyamine-based small molecule epigenetic modulators
Shiv K Sharma, Stuart Hazeldine, Michael L Crowley, et al.
Page
of 1